Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy
科研动态Nature Medicine
2026-10-19
Quadruplet therapy, combining anti-CD38 antibodies, immunomodulatory drugs, proteasome inhibitors and dexamethasone, is …
原文：Nature Medicine（本页为平台整理的中文摘要，逐句对照原文核对后发布）